biomed realty trust inc (BMR) Key Developments
BioMed Realty Trust, Inc. and Illumina Signs 20-Year Lease for New and Innovative Scientific Research Building in Cambridge, England
Jun 25 15
BioMed Realty Trust Inc. announced that Illumina Inc. has signed a 20-year lease for a 155,000 square foot new and innovative scientific research building in Cambridge, England. The project will provide Illumina a collaborative environment and access to the highly skilled workforce in the dynamic research cluster anchored by Cambridge University. The project advances design, with plans to be able to seamlessly expand by 70,000 square feet into a 225,000 square foot building. BioMed Realty acquired the land for the project from The Welding Institute under a long term ground lease, enlarging BioMed Realty'sGranta Park campus in Cambridge, England.
BioMed Realty Trust, Inc. Declares Second Quarter 2015 Dividend, Payable on July 15, 2015
Jun 15 15
BioMed Realty Trust Inc. announced that its board of directors has declared a second quarter 2015 dividend of $0.26 per share of common stock. The dividend is equivalent to an annualized dividend of $1.04 per common share. The common stock dividend is payable on July 15, 2015 to stockholders of record at the close of business on June 30, 2015.
BioMed Realty Trust Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for Second, Third, Fourth Quarter and the Full Year 2015
Apr 28 15
BioMed Realty Trust Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company's total revenues were $178.0 million compared with $168.9 million a year ago. Net income was $20.8 million compared with $20.8 million a year ago. Net income attributable to the company was $17.3 million or $0.08 per basic and diluted share compared with $18.8 million or $0.10 per basic and diluted share a year ago. FFO attributable to common shares and units was $85.3 million or $0.41 per diluted share compared with $83.4 million or $0.40 per diluted share a year ago. CFFO was $85.7 million or $0.41 per diluted share compared with $84.6 million or $0.41 per diluted share a year ago. AFFO attributable to common shares and units was $75.4 million or $0.36 per diluted share compared with $79.5 million or $0.38 per diluted share a year ago. Rental revenue was $118 million for the quarter, down slightly as a result of the cessation of rents from recent opportunistic lease terminations and the sale of 9911 Belward Campus Drive asset in the fourth quarter of 2014. Significant items impacting CFFO and FFO included an approximate $0.08 benefit from lease termination revenue recognized in the quarter, including fees received from Vertex.
For the second and third quarters, the company expects cash, same property NOI to decline between 4% and 6% in each quarter.
Fourth quarter results will improve, but will still be down year-over-year approximately 1%.
For 2015, the company projected net income per diluted share attributable to common stockholders in the range of $0.32 to $0.40. The company projected FFO and CFFO per diluted share in the range of $1.61 to $1.69.
BioMed Realty Trust Inc. Presents at REITWEEK 2015: NAREIT's Investor Forum, Jun-10-2015 09:30 AM
Apr 25 15
BioMed Realty Trust Inc. Presents at REITWEEK 2015: NAREIT's Investor Forum, Jun-10-2015 09:30 AM. Venue: New York Hilton Midtown, 1335 Avenue of the Americas, New York, NY 10019, United States. Speakers: Alan D. Gold, Co-Founder, Chairman, Chief Executive Officer and President, Greg N. Lubushkin, Chief Financial Officer.
BioMed Realty Trust Inc. to Report Q1, 2015 Results on Apr 28, 2015
Apr 17 15
BioMed Realty Trust Inc. announced that they will report Q1, 2015 results at 5:00 PM, Eastern Standard Time on Apr 28, 2015